NCT04238819 2026-03-02
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Phase 1/2 Completed
Eli Lilly and Company
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris
St. Jude Children's Research Hospital
Massachusetts General Hospital